Journal article
Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysis
Abstract
OBJECTIVES: Most randomized controlled trials (RCTs) in SLE have failed to reach their respective end points, with the rates of response to placebo (plus standard-of-care treatment) being unexpectedly high. The aim of this systematic review was to quantify the response to placebo in non-renal, non-neuropsychiatric lupus.
METHODS: The PubMed database was searched (from 2000 to December 2019) for phase II/III RCTs assessing the efficacy and …
Authors
Tselios K; Wakani L; Gladman DD; Su J; Urowitz MB
Journal
Rheumatology, Vol. 60, No. 1, pp. 73–80
Publisher
Oxford University Press (OUP)
Publication Date
January 5, 2021
DOI
10.1093/rheumatology/keaa655
ISSN
1462-0324